House and Senate lawmakers from both parties are working with the Trump administration on proposals that would use drug ...

The FDA on Tuesday said it is planning on doing more surprise inspections of foreign factories, a day after Trump signed an ...

The European Union is committing €500 million ($556 million) over the next two years to make Europe a “magnet” for ...

Marty Makary named Vinay Prasad as the next director of the Center for Biologics and Research, Endpoints News has learned.

Vertex paused an early-stage trial of its inhaled treatment for cystic fibrosis that came from a partnership with Moderna.

Plus, news about Atara Bio­ther­a­peu­tics, Im­mutep, blue­bird bio, OSE Im­munother­a­peu­tics, Mer­sana Ther­a­peu­tics, ...

NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...

Aldeyra Therapeutics reports Phase 3 success with reproxalap for dry eye disease, plans third FDA filing after previous ...

A Singapore-based startup raised a $45 million Series B to start testing a gene therapy in humans next year for a genetic ...

Several members of an FDA advisory committee warned on Monday that new data from studies on long-term use of opioids might ...

Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...

PTC Therapeutics announced Monday that its splicing drug for Huntington’s disease met the primary endpoint of a Phase 2 study ...